Coincident involvement of flvi-2, c-myc, and novel env genes in natural and experimental lymphosarcomas induced by feline leukemia virus.
The flvi-2 locus is a target of insertional mutagenesis in thymic lymphosarcomas induced by feline leukemia virus (FeLV). flvi-2 encodes the gene bmi-1, whose product is implicated as a myc-collaborator in the induction of B- and T-cell lymphoma. We have examined the involvement of flvi-2 and myc in natural and experimentally induced FeLV-positive feline lymphosarcomas which are heterogeneous in anatomical origin, geographic origin, and strain of FeLV involved. We further compared these findings with previous reports of novel FeLV env genes in the same tumors. The results show that proviral insertion at flvi-2 occurs commonly in natural and experimental feline thymic lymphosarcomas of diverse origins [52% overall], and that alterations in c-myc commonly accompany insertional mutagenesis of flvi-2 [54% overall]. However, 46% of tumors with flvi-2 insertions apparently lack involvement of c-myc. These observations support the hypothesis that interruption of flvi-2 may be an early event in a multistep cascade, one possibility for completion of which is activation of c-myc. Interruption of flvi-2 was not observed in nonthymic lymphosarcomas of alimentary or multicentric origin, although c-myc may be involved. A proportion of both thymic and nonthymic tumors have been shown previously to contain FeLV proviruses with recombinant or mutant env genes. Our findings strongly implicate the insertional mutagenesis of flvi-2, the activation of c-myc, and the emergence of novel env genes in FeLV-mediated lymphomagenesis, particularly in the induction of thymic lymphosarcoma. The data show that these events may overlap, but do not necessarily occur concurrently.
Department of Microbiology and Immunology SL-38, Tulane University School of Medicine, New Orleans, Louisiana 70112.
L S
LS
Levy
P A
PA
Lobelle-Rich
J
J
Overbaugh
J L
JL
Abkowitz
R
R
Fulton
P
P
Roy-Burman
D000818:Animals; D002415:Cats; D005814:Genes, Viral / Q000235:genetics*; D015752:Genes, env / Q000235:genetics; D016259:Genes, myc / Q000235:genetics; D005256:Leukemia Virus, Feline / Q000235:genetics*; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics / Q000382:microbiology / Q000662:veterinary*; D016254:Mutagenesis, Insertional; D009374:Neoplasms, Experimental / Q000235:genetics / Q000382:microbiology; D009687:Nuclear Proteins / Q000235:genetics; D011518:Proto-Oncogene Proteins; D013953:Thymus Neoplasms / Q000235:genetics / Q000382:microbiology / Q000662:veterinary*
D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins